Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients With Mantle Cell Lymphoma Treated With Novel Agents

NCT03816683 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03816683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03816683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients With Mantle Cell Lymphoma Treated With Novel Agents
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 1, 2019
Completion date
March 18, 2024
Enrollment
227 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma